Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# Randal Kirk

Random fact: Sold New River Pharmaceuticals to Shire for $2.6 billion in 2007.

Overview

Kirk is chairman and largest shareholder of Intrexon, a publicly traded U.S. biotechnology company. The Germantown, Maryland-based business designs and makes modular DNA systems. Through his Radford, Virginia-based investment vehicle, Third Security, he owns stakes in more than a dozen publicly traded companies.

As of Jan. 21, 2018:
Last change ()
YTD change ()
Industry Biotechnology
Biggest asset N/A
Citizenship United States
Age 63
Wealth Self-made
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Randal Kirk's net worth of can buy ...

0
troy ounces of gold
0
barrels of crude oil

... and is equivalent to ...

0%
of the GDP of the United States
0%
of the total wealth of the 500 richest people in the world
0%
of the top 100 U.S. college endowments
0%
of the top 200 U.S. executives’ total awarded compensation
0%
of U.S. existing home sales
0
times the median U.S. household income

Latest News

Net Worth Summary

Cash
Private asset
Public asset
Misc. liabilities
Confidence rating:

Biography

Birthdate: 3/10/1953
Family: Divorced, 4 children
Education: University of Virginia, JD Radford University, Bachelor's Degree, Business

The son of an Air Force sergeant, Randal J. Kirk was born March 10, 1953, on a military base in Pleasanton, California. He spent most of his childhood in Virginia and attended Radford University, graduating with a degree in business in 1976. Three years later, he received a degree from the University of Virginia School of Law.

While practicing as an attorney, he partnered with local investor, John Gregory, to found perishable-drug distributor General Injectables and Vaccines in 1983. He sold it 15 years later for $65 million in cash. He donated $1 million to his alma mater, Radford University, the same year. It was the largest gift the school had ever received from an alumnus.

After the sale, Kirk founded New River Pharmaceuticals, focusing on making safer, improved versions of existing drugs. The company's biggest success came with Vynase, an attention deficit disorder medication. Shortly after the treatment won FDA approval in 2007, Kirk sold the company to Dublin, Ireland-based Shire for $2.6 billion. He had another payout in 2011, when he sold an antidepressant maker Clinical Data to New York-based Forest Laboratories for $1.2 billion. Between the two deals, Kirk received more than $1.8 billion.

Over the next few years, Kirk invested about $200 million into Intrexon, a biotechnology company that designs and makes artificial cell systems for use in human therapies, agriculture, industrial products and other applications. He owns more than half of the Germantown, Maryland-based company that sold shares to the public in August 2013.

The billionaire, who is divorced and has four children, lives in Florida and Virginia.

Milestones
  • 1953 Randal Kirk is born in California.
  • 1976 Graduates from Radford University.
  • 1979 Receives degree from University of Virginia School of Law.
  • 1983 Co-founds General Injectables and Vaccines.
  • 1998 Sells General Injectables and Vaccines for $65 million.
  • 2007 Sells New River Pharmaceuticals to Shire for $2.6 billion.
  • 2008 Becomes chairman of Intrexon.
  • 2013 Intrexon sells shares on the New York Stock Exchange.